Humanigen, Inc. (HGEN) Social Stream



Humanigen, Inc. (HGEN): $0.14

-0.01 (-4.35%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add HGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#148 of 401

in industry

HUMANIGEN INC (HGEN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HUMANIGEN INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 6 $35 $9 $23 $0.149 15336.24%
2021-11-18 7 $30 $9 $20.6 $0.149 13725.5%
2022-01-03 6 $30 $9 $20.6 $0.149 13725.5%
2022-02-04 6 $30 $9 $19.6 $0.149 13054.36%
2022-03-01 6 $30 $9 $19.4 $0.149 12920.13%
2022-05-06 6 $30 $9 $19 $0.149 12651.68%
2022-07-13 4 $9 $2 $5.5 $0.149 3591.28%
2022-08-15 3 $9 $2 $5.5 $0.149 3591.28%
2022-11-15 2 $9 $1 $5 $0.149 3255.7%
2022-11-17 3 $9 $1 $5 $0.149 3255.7%
2023-01-12 4 $9 $0.15 $3.383 $0.149 2170.47%
2023-03-31 2 $9 $0.15 $4.575 $0.149 2970.47%
2023-05-16 1 $0.15 $0.15 $0.15 $0.149 0.67%

The Trend in the Analyst Price Target


HGEN's average price target has moved down $22.85 over the prior 19 months.

Over the past 44 weeks, HGEN's average upside potential has been 1,561.22%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-15 2 9.00 2.00 5.500 0.383 1336.03%
2023-01-12 3 9.00 0.15 4.575 0.165 2672.73%
2023-01-12 4 9.00 0.15 3.383 0.165 1950.3%
2023-03-31 1 9.00 0.15 4.575 0.143 3099.3%
2023-05-16 1 0.15 0.15 0.150 0.149 0.67%

HGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


HGEN's average broker recommendation rating improved by 0 over the prior 26 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how HUMANIGEN INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1708.83% of that group.
  • In terms of how HUMANIGEN INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1480.15% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, HUMANIGEN INC's average analyst price target is higher than 356.84% of them.
  • In terms of how HUMANIGEN INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 841.05% of that group.

Stocks similar to HUMANIGEN INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MNOV, SVRA, and BPTH.

Is HGEN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.701 seconds.